Flexible Reinforced Laryngeal Mask Airway Versus Endotracheal Tube for Childhood Adenotonsillectomy
Airway Management Effects of Flexible Reinforced Laryngeal Mask Airway Versus Endotracheal Tube for Childhood Adenotonsillectomy:a Randomized Controlled Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
The goal of this clinical trial is to compare the airway management effects of flexible reinforced laryngeal mask and endotracheal tube in childhood adenotonsillectomy. Participants will be randomly allocated to two groups: endotracheal tube group (ETT) and flexible reinforced laryngeal mask group (FLMA). For those in ETT group: they will be intubated after induction of anesthesia .For those in FLMA group: they will be put in flexible reinforced laryngeal mask after induction of anesthesia . The investigators will compare FLMA with ETT to see if flexible reinforced laryngeal mask can be used safely and effectively in childhood adenotonsillectomy,and if there will be less severe adverse events in FLMA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Aug 2023
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
April 4, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedApril 24, 2024
April 1, 2024
5 months
April 4, 2024
April 20, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Peak airway pressure
Maximum peak airway pressure during surgery
intraoperative period,10 minutes-1 hours
Petco2
Petco2 at the end of surgery
intraoperative period,10 minutes-1 hour
Ventilation leakage or not
Using volume ventilation, tidal volume set to 10 ml /kg, Ventilation leakage is defined as reaching more than 20% of the set tidal volume.
intraoperative period,10 minutes-1 hour
Secondary Outcomes (8)
Mean arterial pressure (MAP)
Intraoperative period, 30 minutes - 1.5 hours
Heart rate (HR)
Intraoperative period, 30 min - 1.5 hours
Recovery time
Postoperative 30 minutes
Extubation time
Postoperative 30 minutes
Dosage of anesthetic
Intraoperative period, 30 minutes - 1.5 hours
- +3 more secondary outcomes
Study Arms (2)
FLMA group
EXPERIMENTALIn the FLMA group, a FLMA was applied.
ETT group
EXPERIMENTALIn the ETT group, guided by a visual laryngoscope, a ETT was intubated.
Interventions
In the FLMA group, a FLMA was applied according to the manufacturer's recommendations. After lubrication of the posterior surface with oxybuprocaine hydrochloride gel, the FLMA was inserted after propping the shoulders. Its cuff was fully deflated before insertion, and the pressure was adjusted to 40 cm H2O with a manometer after insertion.
In the ETT group, guided by a visual laryngoscope, a ETT was intubated after lubrication of the surface with oxybuprocaine hydrochloride gel: endotracheal tube size = (16+ age) /4. The cuff pressure of ETT was adjusted to 20 cm H2O with a handheld manometer after inflation.
Eligibility Criteria
You may qualify if:
- patients who choose to have adenotonsillectomy surgery
- the American Society of Anesthesiologists (ASA) physical status ranked I-II
- the oropharyngeal anatomy is normal
- competent to provide informed consent
You may not qualify if:
- upper respiratory tract infection one week before surgery
- oropharyngeal anatomy is abnormal
- high risk of reflux aspiration
- liver or kidney failure
- psychiatric disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maternal and Child Health Hospital of Hubei Province
Wuhan, Hubei, 430000, China
Study Officials
- PRINCIPAL INVESTIGATOR
Na Li, MD
Maternal and Child Health Hospital of Hubei Province
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Chief Physician
Study Record Dates
First Submitted
April 4, 2024
First Posted
April 10, 2024
Study Start
August 1, 2023
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
April 24, 2024
Record last verified: 2024-04